Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of 13-valent Pneumococcal Conjugate Vaccine (ATG-PCV13) in Infants
NCT05759520Phase 3Active, not recruiting
- Start
- Nov 2022
- Primary completion
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of anti-thymocyte globulin + PCV13 in Streptococcus pneumoniae infection. Started Nov 2022; status: active, not recruiting.
02
Drugs
anti-thymocyte globulin + PCV13
03
Conditions
Streptococcus pneumoniae infection
Beyond the preview
Go deeper on NCT05759520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05759520.